Wang, W., Groves, M. R., & Domling, A. (2018). Artificial macrocycles as IL-17A/IL-17RA antagonists. MedChemCommun, 9(1), 22-26. https://doi.org/10.1039/c7md00464h

Shaabani, S., Neochoritis, C. G., Twarda-Clapa, A., Musielak, B., Holak, T. A., & Domling, A. (2017). Scaffold hopping via ANCHOR.QUERY: beta-lactams as potent p53-MDM2 antagonists. MedChemCommun, 8(5), 1046-1052. https://doi.org/10.1039/c7md00058h

Swier, L. J. Y. M., Monjas, L., Reeßing, F., Oudshoorn, R. C., Aisyah, A., Primke, T., Bakker, M. M., Van Olst, E., Ritschel, T., Faustino, I., Marrink, S. J., Hirsch, A. K. H., & Slotboom, D. J. (2017). Insight into the complete substrate-binding pocket of ThiT by chemical and genetic mutations. MedChemCommun, 8(5), 1121-1130. https://doi.org/10.1039/C7MD00079K

Ourailidou, M. E., Leus, N. G. J., Krist, K., Lenoci, A., Mai, A., & Dekker, F. J. (2016). Chemical epigenetics to assess the role of HDAC1-3 inhibition in macrophage pro-inflammatory gene expression. MedChemCommun, 7(11), 2184-2190. https://doi.org/10.1039/c6md00375c

Ourailidou, M. E., Zwinderman, M. R. H., & Dekker, F. (2016). Bioorthogonal metabolic labelling with acyl-CoA reporters: targeting protein acylation. MedChemCommun, 7(3), 399-408. https://doi.org/10.1039/c5md00446b

Monjas , L., Swier, L. J. Y. M., de Voogd, A. R., Oudshoorn, R. C., Hirsch, A. K. H., & Slotboom, D. J. (2016). Design and synthesis of thiamine analogues to study their binding to the ECF transporter for thiamine in bacteria. MedChemCommun, 7(5), 966-971. https://doi.org/10.1039/c6md00022c

Mondal, M., Groothuis, D. E., & Hirsch, A. K. H. (2015). Fragment growing exploiting dynamic combinatorial chemistry of inhibitors of the aspartic protease endothiapepsin. MedChemCommun, 6(7), 1267-1271. https://doi.org/10.1039/c5md00157a

de Almeida, A., Soveral, G., & Casini, A. (2014). Gold compounds as aquaporin inhibitors: New opportunities for therapy and imaging. MedChemComm, 5(10), 1444-1453. https://doi.org/10.1039/c4md00265b

Serratice, M., Bertrand, B., Janssen, E. F. J., Hemelt, E., Zucca, A., Cocco, F., Cinellu, M. A., & Casini, A. (2014). Gold(I) compounds with lansoprazole-type ligands: synthesis, characterization and anticancer properties in vitro. MedChemComm, 5(9), 1418-1422. https://doi.org/10.1039/c4md00241e

Boltjes, A., Liao, G. P., Zhao, T., Herdtweck, E., & Doemling, A. (2014). Ugi 4-CR synthesis of gamma- and delta-lactams providing new access to diverse enzyme interactions: a PDB analysis. MedChemCommun, 5(7), 949-952. https://doi.org/10.1039/C4MD00162A

Khoury, K., Popowicz, G. M., Holak, T. A., & Doemling, A. (2011). The p53-MDM2/MDMX axis - A chemotype perspective. MedChemComm, 2(4), 246-260. https://doi.org/10.1039/c0md00248h

Gabbiani, C., Mastrobuoni, G., Sorrentino, F., Dani, B., Rigobello, M. P., Bindoli, A., Cinellu, M. A., Pieraccini, G., Messori, L., & Casini, A. (2011). Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(III) compounds studied with combined mass spectrometry and biochemical assays. MedChemComm, 2(1), 50-54. https://doi.org/10.1039/c0md00181c